I am trying to locate papers covering the implications or benefits associated with the administration sequence of chemotherapy drugs, to patients receiving day treatment.This is outside of the rule vesicants, followed by irritants with vesicant properties etc. This is pertinent to cases where both drugs to be administered are irritants for example.
Notes about answers
If you see something you feel is wrong, don’t criticise (that misses the point of Triple) courteously and supportively give a counter answer.
Answers given should be in good faith, but they should not be considered definitive, be critical.
We do not endorse or verify content posted by users.
Thanks for your response,
Thanks for your question,
- Answered 12 Jan 2020 Conflict of interest declaration: None A user emailed me the following (thanks Chris): This is the best I can find - there are a number of articles that the reader can explore fully referenced and some that appear to be more opinion or guideline based - the answer is in there! Chemotherapy Administration Sequence: A Review of the Literature and Creation of a Sequencing Chart http://www.jhoponline.com/breast-cancer-articles?view=article&artid=13240:top-13240&catid=3321 Guidelines for the administration of chemotherapy for malignant disease https://www.england.nhs.uk/mids-east/wp-content/uploads/sites/7/2018/04/guidelines-administration-chemotherapy-for-malignant-disease-v2-1-0.pdf Overview, prevention and management of chemotherapy extravasation https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734939/ Chemotherapy drug sequencing guide https://hemonc.org/docs/chemotherapysequences.pdf Efficacy with a Replication-selective Adenovirus Plus Cisplatinbased Chemotherapy: Dependence on Sequencing but not p53 Functional Status or Route of Administration https://pdfs.semanticscholar.org/4f5f/68bf6c3fd6bb0de00d406e2bc09e80f73714.pdf Chemotherapy administration sequences -Review of the literature & administration recommendations https://ascopubs.org/doi/abs/10.1200/jco.2005.23.16_suppl.6121 Chemotherapy Administration Sequencing Chart http://www.valuebasedcancer.com/issue-archive/2012/march-2012-vol-3-no-2/vbcc-1791/